Lavista Pharma SRL
7.2 FTELavista Pharma reported total assets of €2.47m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026), with 7.2 full-time equivalents.
The score of Lavista Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +24 % Total assets +110 % Headcount (avg FTE) +29 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lavista Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 153,210 € | ||||
| Equity | 789,600 € | ||||
| Cash | 12,841 € | ||||
| EBITDA | 333,251 € | ||||
| Total assets | €2.47m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 06 Aug 2024
- Year ended 31 Dec 2022filed on 15 Jun 2023
- Year ended 31 Dec 2021filed on 08 Jul 2022
Lavista Pharma's financial analysis
- Solvency31.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lavista Pharma
Lavista Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0816.918.063
- VAT number
- BE0816918063
- Peppol
- Registered · 0208:0816918063 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Jul 2009
- Registered office
- 6181 Courcelles
- Size
- Micro · 7.2 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Lavista Pharma (SRL) has been based in Courcelles since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 153,210 € and equity of 789,600 €; its revenue is not published. With 7.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 31.9%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Lavista Pharma
Companies in the same business, of comparable size and area, outside its group.
- JLV Consult Retail sale of pharmaceutical products Thuin · balance sheet €2.53m
- Apotheek de Rijn Retail sale of pharmaceutical products Retie · balance sheet €1.94m
- Management Lormans-Bekkers Retail sale of pharmaceutical products Beringen · balance sheet €1.84m
- Global-E-Care Retail sale of pharmaceutical products Antwerp · balance sheet €1.41m
- Vanlerberghe Invest Retail sale of pharmaceutical products Torhout · balance sheet €1.38m
- Herseltpharma Retail sale of pharmaceutical products Herselt · balance sheet €1.31m
- Pharmacie Stassen-BYA Retail sale of pharmaceutical products Juprelle · balance sheet €1.18m
- Pharmarive Retail sale of pharmaceutical products Etterbeek · balance sheet €1.80m
Frequently asked questions about Lavista Pharma
What is the revenue of Lavista Pharma?
Lavista Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lavista Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0816918063 for Lavista Pharma, if the company is VAT-registered. Its company number (CBE) is 0816.918.063.
Where is the registered office of Lavista Pharma?
According to the CBE register, the registered office of Lavista Pharma is in 6181 Courcelles.
What is the equity of Lavista Pharma?
At the close of the 2025 financial year, the equity of Lavista Pharma amounts to 789,600 €, a solvency of 31.9% of total assets.
How many people work at Lavista Pharma?
7.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Lavista Pharma?
The register lists 1 active mandates at Lavista Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lavista Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →